miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis | |
Song, Changshan[1]; Lu, Pingfang[2]; Sun, Guoqiang[2]; Yang, Lin[3]; Wang, Zhigang[2]; Wang, Zheng[3] | |
2017 | |
卷号 | 482期号:[db:dc_citation_issue]页码:22 |
DOI | [db:dc_identifier_doi] |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3352234 |
专题 | 暨南大学 |
作者单位 | 1.[1]Jinan Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510630, Guangdong, Peoples R China 2.[2]Guangdong Med Univ, Affiliated Hosp, Dept Thorac Surg, Zhanjiang 524023, Guangdong, Peoples R China 3.[3]Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Thorac Surg, Shenzhen 518020, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Song, Changshan[1],Lu, Pingfang[2],Sun, Guoqiang[2],et al. miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis[J],2017,482([db:dc_citation_issue]):22. |
APA | Song, Changshan[1],Lu, Pingfang[2],Sun, Guoqiang[2],Yang, Lin[3],Wang, Zhigang[2],&Wang, Zheng[3].(2017).miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.,482([db:dc_citation_issue]),22. |
MLA | Song, Changshan[1],et al."miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis".482.[db:dc_citation_issue](2017):22. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论